GLAXOSMITHKLINE FDA Approval ANDA 062321

ANDA 062321

GLAXOSMITHKLINE

FDA Drug Application

Application #062321

Application Sponsors

ANDA 062321GLAXOSMITHKLINE

Marketing Status

Discontinued001

Application Products

001FOR SOLUTION;ORALEQ 250MG BASE/5ML0BACTOCILLOXACILLIN SODIUM

FDA Submissions

ORIG1AP1981-06-02

Submissions Property Types

ORIG1Null29

CDER Filings

GLAXOSMITHKLINE
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 62321
            [companyName] => GLAXOSMITHKLINE
            [docInserts] => ["",""]
            [products] => [{"drugName":"BACTOCILL","activeIngredients":"OXACILLIN SODIUM","strength":"EQ 250MG BASE\/5ML","dosageForm":"FOR SOLUTION;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"BACTOCILL","submission":"OXACILLIN SODIUM","actionType":"EQ 250MG BASE\/5ML","submissionClassification":"FOR SOLUTION;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.